Resultats de la cerca - Maria Alma Rodriguez
- Mostrar 1 - 20 resultats de 56
- Anar a la pàgina següent
-
1
-
2
Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma per Lorenzo Cohen, Carla L. Warneke, Rachel T. Fouladi, Maria Alma Rodriguez, Alejandro Chaoul‐Reich
Publicat 2004Artigo -
3
Original article: A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the ‘tumor score’ per José Rodríguez, Fernando Cabanillas, Peter McLaughlin, F Swan, Maria Alma Rodriguez, Frederick Hagemeister, Jorge Romaguera
Publicat 1992Artigo -
4
-
5
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma per Maria Alma Rodriguez, Robert Pytlík, Tomáš Kozák, Mukesh Chhanabhai, Randy D. Gascoyne, Biao Lu, Steven R. Deitcher, Jane N. Winter
Publicat 2009Artigo -
6
-
7
-
8
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin’s lymphoma per Chitra Hosing, Rima M. Saliba, Peter McLaughlin, Börje S. Andersson, Maria Alma Rodriguez, Laura M. Fayad, Fernando Cabanillas, Richard E. Champlin, Issa F. Khouri
Publicat 2003Artigo -
9
-
10
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease per Anas Younes, Jorge Romaguera, Frederick Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Paolo Fiumara, André Goy, Sima Jeha, John T. Manning, Dan Jones, Lynne V. Abruzzo, L. Jeffrey Medeiros
Publicat 2003Artigo -
11
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia per Deborah A. Thomas, Andreas H. Sarris, Jorge E. Cortés, Stefan Faderl, Susan O’Brien, Francis J. Giles, Guillermo Garcia‐Manero, Maria Alma Rodriguez, Fernando Cabanillas, Hagop M. Kantarjian
Publicat 2005Artigo -
12
Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network per Ann S. LaCasce, Michelle E. Kho, Jonathan W. Friedberg, Joyce C. Niland, Gregory A. Abel, Maria Alma Rodriguez, Myron S. Czuczman, Michael Millenson, Andrew D. Zelenetz, Jane C. Weeks
Publicat 2008Artigo -
13
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next‐generation sequencing approach per Yasuhiro Oki, Sattva S. Neelapu, Michelle A. Fanale, Larry W. Kwak, Luis Fayad, Maria Alma Rodriguez, Michael B. Wallace, Mark Klinger, Victoria Carlton, Katherine A. Kong, Malek Faham, Anas Younes
Publicat 2015Artigo -
14
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma per Barbara Pro, Brian Leber, Mitchell R. Smith, Luis Fayad, Jorge Romaguera, Fredrick B. Hagemeister, Maria Alma Rodriguez, Peter McLaughlin, Felipe Samaniego, James A. Zwiebel, Adriana López, Larry W. Kwak, Anas Younes
Publicat 2008Artigo -
15
Phase II Study of Yttrium-90–Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma per Michael Wang, Yasuhiro Oki, Barbara Pro, Jorge Romaguera, Maria Alma Rodriguez, Felipe Samaniego, Peter McLaughlin, Frederick Hagemeister, Sattva S. Neelapu, Amanda Copeland, Barry I. Samuels, Evelyne M. Loyer, Yuan Ji, Anas Younes
Publicat 2009Artigo -
16
Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy per Mani Akhtari, Jay P. Reddy, Chelsea C. Pinnix, Pamela K. Allen, E.M. Osborne, Jillian R. Gunther, Sarah A. Milgrom, Grace L. Smith, Christine F. Wogan, Nathan Fowler, Maria Alma Rodriguez, Bouthaina S. Dabaja
Publicat 2015Artigo -
17
Phase II trial of denileukin diftitox for relapsed/refractory T‐cell non‐Hodgkin lymphoma per Nam H. Dang, Barbara Pro, Fredrick B. Hagemeister, Felipe Samaniego, Dan Jones, Barry I. Samuels, Maria Alma Rodriguez, André Goy, Jorge Romaguera, Peter McLaughlin, Ann T. Tong, Francesco Turturro, Pamela L. Walker, Luis Fayad
Publicat 2006Artigo -
18
Radiation for diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era: Analysis of the <scp>N</scp>ational <scp>C</scp>omprehensive <scp>C</scp>ancer <scp>N</scp>etwork lymph... per Bouthaina S. Dabaja, Ann Vanderplas, Allison Crosby‐Thompson, Gregory A. Abel, Myron S. Czuczman, Jonathan W. Friedberg, Leo I. Gordon, Mark Kaminski, Joyce C. Niland, Michael Millenson, Auayporn Nademanee, Andrew D. Zelenetz, Ann S. LaCasce, Maria Alma Rodriguez
Publicat 2014Artigo -
19
Risk Factors, Treatment, and Outcome of Central Nervous System Recurrence in Adults With Intermediate-Grade and Immunoblastic Lymphoma per Koen van Besien, Chul S. Ha, Sandy Murphy, Peter McLaughlin, Maria Alma Rodriguez, Kamal Adel Amin, Arthur Forman, Jorge Romaguera, Fredrick Hagemeister, Anas Younes, Carlos Bachier, Andreas H. Sarris, Kathleen S. Sobocinski, James D. Cox, Fernando Cabanillas
Publicat 1998Artigo -
20
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma per Yasuhiro Oki, Hubert H. Chuang, Beth Chasen, Aaron Jessop, Tinsu Pan, Michelle A. Fanale, Bouthaina S. Dabaja, Nathan Fowler, Jorge Romaguera, Luis Fayad, Fredrick B. Hagemeister, Maria Alma Rodriguez, Sattva S. Neelapu, Felipe Samaniego, Larry W. Kwak, Anas Younes
Publicat 2014Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Lymphoma
Oncology
Gastroenterology
Chemotherapy
Surgery
Rituximab
Cancer
Biology
Cyclophosphamide
Immunology
Vincristine
Astrobiology
Physics
Refractory (planetary science)
Pathology
Survivorship curve
Biochemistry
Cancer survivorship
Diffuse large B-cell lymphoma
Economics
Family medicine
Hodgkin lymphoma
International Prognostic Index
Gerontology
Mantle cell lymphoma
Adverse effect
Cancer survivor
Economic growth